Price Packages
Service Features
  • 275 words per page
  • Font: 12 point Courier New
  • Double line spacing
  • Free unlimited paper revisions
  • Free bibliography
  • Any citation style
  • No delivery charges
  • SMS alert on paper done
  • No plagiarism
  • Direct paper download
  • Original and creative work
  • Researched any subject
  • 24/7 customer support

It is sometimes difficult to be inspired when trying to write a persuasive essay, book report or thoughtful research paper. Often of times, it is hard to find words that best describe your ideas. VIPessays now provides a database of over 150,000 quotations and proverbs from the famous inventors, philosophers, sportsmen, artists, celebrities, business people, and authors that are aimed to enrich and strengthen your essay, term paper, book report, thesis or research paper.

Try our free search of constantly updated quotations and proverbs database.

QuotationsAuthorsTopicsKeywords

Search over 150,000 Quotations & Proverbs
Browse Authors: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
(Click a letter to view the authors)
Letter "G" » Glenn Reicin Quotes
«As such, we do not see any incremental financial impact from [Thursday's] action.»
Author: Glenn Reicin
«The device replacements will cause companies to forgo revenue producing replacement units in future years.»
Author: Glenn Reicin
«Greater clarity regarding this transaction and future growth goals (without the Guidant acquisition) are needed,»
Author: Glenn Reicin
«We believe it will be critical for BSX to carefully manage its interaction with the FDA,»
Author: Glenn Reicin
«Greater clarity regarding this transaction and future growth goals (without the Guidant acquisition) are needed.»
Author: Glenn Reicin
«We believe it will be critical for BSX to carefully manage its interaction with the FDA.»
Author: Glenn Reicin
«J&J needs Guidant's deep middle-management bench and the cooperation of senior management.»
Author: Glenn Reicin
«Results were dramatically lower than consensus estimates in both cases and reflect the challenges the company faces in rebuilding its CRM [cardiac rhythm management] business.»
Author: Glenn Reicin
«Boston Scientific still has much 'wood to chop' regarding the recovery of the company's cardiac rhythm management business...That said, we believe earnings power for businesses remain substantial.»
Author: Glenn Reicin
«Overall, we found results in the quarter to be generally weak, but believe the strong market reaction was justified given the anticipated completion of the Guidant vascular acquisition.»
Author: Glenn Reicin
Research our database of over 800,000 top-quality pre-written papers plus 15,000 biographies for only $9.95/month.
Instant Account Activation. Register Now.